Chery Zimberlin, Ph.D.
Board Member, Indi Molecular

Principal, M Ventures

Cheryl Zimberlin, Ph.D., is a principal at M Ventures, the corporate Venture Capital arm of Merck KgAA, Darmstadt, Germany. M Ventures takes an active role in company creation and investment, with the mandate to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business. Prior to joining the team she had a successful academic career, publishing in top-tier academic journals, including Nature. She holds a PhD in Oncology and MSc in Biotechnology. Currently she holds board positions in several M Ventures portfolio companies.